Changes in intracranial pressure, coagulation, and neurologic outcome after resuscitation from experimental traumatic brain injury with hetastarch

David R. King, Stephen M. Cohn, Kenneth G Proctor

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Background In a model of traumatic brain injury (TBI), 2 protocols compared changes in intracranial pressure (ICP), coagulation, and neurologic outcome after intravenous fluid (IVF) resuscitation with either Hextend (HEX, 6% hetastarch in lactated electrolyte injection) or standard of care, crystalloid plus mannitol (MAN). Methods In the nonsurvivor protocol, swine (n=28) received a fluid percussion TBI and hemorrhage (27 ± 3 mL/kg). At 30 minutes, resuscitation began with lactated Ringer's (LR) or HEX. After 60 minutes, MAN (1 g/kg) or placebo was given plus supplemental IVF to maintain cerebral perfusion pressure (CPP) ≥70 mm Hg for 240 minutes. Swine in the survivor group (n=15) also underwent TBI and hemorrhage, and resuscitation with HEX was compared to that of normal saline (NS)+MAN. Neurologic outcome and coagulation were evaluated for 72 hours. Results In the nonsurvivor protocol, HEX, LR+MAN, and HEX+MAN attenuated the time-related rise of ICP and prevented ICP >20 mm Hg versus LR alone (P < .05). HEX alone maintained CPP (relative to baseline) and decreased total IVF by 50% versus LR ± MAN (P < .05). MAN had no additive effect with HEX. Coagulation, measured by thromboelastograph reaction time (R), was 11 ± 1 and 9 ± 1 minutes at baseline and after TBI (before randomization). At 240 minutes after HEX or LR+MAN, R was 6 ± 1 or 7 ± 2 minutes, which indicates a hypercoagulable state, but there was no difference between treatments. In the survivor protocol, ICP and CPP were similar with NS+MAN versus HEX, but IVF requirement was 161 ± 20 versus 28 ± 3 mL/kg (P < .05). Motor scores were higher on days 2 and 3 with HEX (P < .05). At 72 hours, R was 28 ± 14 versus 26 ± 6 minutes with NS+MAN versus HEX, which indicates a hypocoagulable state, but there was no difference between treatments. Conclusions Hextend as the sole resuscitation fluid after severe TBI reduces fluid requirement, obviates the need for mannitol, improves neurologic outcome, and has no adverse effect on the coagulation profile relative to the crystalloid plus mannitol standard of care.

Original languageEnglish
Pages (from-to)355-363
Number of pages9
JournalSurgery
Volume136
Issue number2
DOIs
StatePublished - Aug 1 2004

Fingerprint

Hydroxyethyl Starch Derivatives
Intracranial Pressure
Mannitol
Resuscitation
Nervous System
Cerebrovascular Circulation
Traumatic Brain Hemorrhage
Standard of Care
Traumatic Brain Injury
Swine
Percussion
Random Allocation
Electrolytes
Reaction Time

ASJC Scopus subject areas

  • Surgery

Cite this

Changes in intracranial pressure, coagulation, and neurologic outcome after resuscitation from experimental traumatic brain injury with hetastarch. / King, David R.; Cohn, Stephen M.; Proctor, Kenneth G.

In: Surgery, Vol. 136, No. 2, 01.08.2004, p. 355-363.

Research output: Contribution to journalArticle

@article{b394ce91db5d4ff0aeba0c3c19db93d8,
title = "Changes in intracranial pressure, coagulation, and neurologic outcome after resuscitation from experimental traumatic brain injury with hetastarch",
abstract = "Background In a model of traumatic brain injury (TBI), 2 protocols compared changes in intracranial pressure (ICP), coagulation, and neurologic outcome after intravenous fluid (IVF) resuscitation with either Hextend (HEX, 6{\%} hetastarch in lactated electrolyte injection) or standard of care, crystalloid plus mannitol (MAN). Methods In the nonsurvivor protocol, swine (n=28) received a fluid percussion TBI and hemorrhage (27 ± 3 mL/kg). At 30 minutes, resuscitation began with lactated Ringer's (LR) or HEX. After 60 minutes, MAN (1 g/kg) or placebo was given plus supplemental IVF to maintain cerebral perfusion pressure (CPP) ≥70 mm Hg for 240 minutes. Swine in the survivor group (n=15) also underwent TBI and hemorrhage, and resuscitation with HEX was compared to that of normal saline (NS)+MAN. Neurologic outcome and coagulation were evaluated for 72 hours. Results In the nonsurvivor protocol, HEX, LR+MAN, and HEX+MAN attenuated the time-related rise of ICP and prevented ICP >20 mm Hg versus LR alone (P < .05). HEX alone maintained CPP (relative to baseline) and decreased total IVF by 50{\%} versus LR ± MAN (P < .05). MAN had no additive effect with HEX. Coagulation, measured by thromboelastograph reaction time (R), was 11 ± 1 and 9 ± 1 minutes at baseline and after TBI (before randomization). At 240 minutes after HEX or LR+MAN, R was 6 ± 1 or 7 ± 2 minutes, which indicates a hypercoagulable state, but there was no difference between treatments. In the survivor protocol, ICP and CPP were similar with NS+MAN versus HEX, but IVF requirement was 161 ± 20 versus 28 ± 3 mL/kg (P < .05). Motor scores were higher on days 2 and 3 with HEX (P < .05). At 72 hours, R was 28 ± 14 versus 26 ± 6 minutes with NS+MAN versus HEX, which indicates a hypocoagulable state, but there was no difference between treatments. Conclusions Hextend as the sole resuscitation fluid after severe TBI reduces fluid requirement, obviates the need for mannitol, improves neurologic outcome, and has no adverse effect on the coagulation profile relative to the crystalloid plus mannitol standard of care.",
author = "King, {David R.} and Cohn, {Stephen M.} and Proctor, {Kenneth G}",
year = "2004",
month = "8",
day = "1",
doi = "10.1016/j.surg.2004.05.011",
language = "English",
volume = "136",
pages = "355--363",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Changes in intracranial pressure, coagulation, and neurologic outcome after resuscitation from experimental traumatic brain injury with hetastarch

AU - King, David R.

AU - Cohn, Stephen M.

AU - Proctor, Kenneth G

PY - 2004/8/1

Y1 - 2004/8/1

N2 - Background In a model of traumatic brain injury (TBI), 2 protocols compared changes in intracranial pressure (ICP), coagulation, and neurologic outcome after intravenous fluid (IVF) resuscitation with either Hextend (HEX, 6% hetastarch in lactated electrolyte injection) or standard of care, crystalloid plus mannitol (MAN). Methods In the nonsurvivor protocol, swine (n=28) received a fluid percussion TBI and hemorrhage (27 ± 3 mL/kg). At 30 minutes, resuscitation began with lactated Ringer's (LR) or HEX. After 60 minutes, MAN (1 g/kg) or placebo was given plus supplemental IVF to maintain cerebral perfusion pressure (CPP) ≥70 mm Hg for 240 minutes. Swine in the survivor group (n=15) also underwent TBI and hemorrhage, and resuscitation with HEX was compared to that of normal saline (NS)+MAN. Neurologic outcome and coagulation were evaluated for 72 hours. Results In the nonsurvivor protocol, HEX, LR+MAN, and HEX+MAN attenuated the time-related rise of ICP and prevented ICP >20 mm Hg versus LR alone (P < .05). HEX alone maintained CPP (relative to baseline) and decreased total IVF by 50% versus LR ± MAN (P < .05). MAN had no additive effect with HEX. Coagulation, measured by thromboelastograph reaction time (R), was 11 ± 1 and 9 ± 1 minutes at baseline and after TBI (before randomization). At 240 minutes after HEX or LR+MAN, R was 6 ± 1 or 7 ± 2 minutes, which indicates a hypercoagulable state, but there was no difference between treatments. In the survivor protocol, ICP and CPP were similar with NS+MAN versus HEX, but IVF requirement was 161 ± 20 versus 28 ± 3 mL/kg (P < .05). Motor scores were higher on days 2 and 3 with HEX (P < .05). At 72 hours, R was 28 ± 14 versus 26 ± 6 minutes with NS+MAN versus HEX, which indicates a hypocoagulable state, but there was no difference between treatments. Conclusions Hextend as the sole resuscitation fluid after severe TBI reduces fluid requirement, obviates the need for mannitol, improves neurologic outcome, and has no adverse effect on the coagulation profile relative to the crystalloid plus mannitol standard of care.

AB - Background In a model of traumatic brain injury (TBI), 2 protocols compared changes in intracranial pressure (ICP), coagulation, and neurologic outcome after intravenous fluid (IVF) resuscitation with either Hextend (HEX, 6% hetastarch in lactated electrolyte injection) or standard of care, crystalloid plus mannitol (MAN). Methods In the nonsurvivor protocol, swine (n=28) received a fluid percussion TBI and hemorrhage (27 ± 3 mL/kg). At 30 minutes, resuscitation began with lactated Ringer's (LR) or HEX. After 60 minutes, MAN (1 g/kg) or placebo was given plus supplemental IVF to maintain cerebral perfusion pressure (CPP) ≥70 mm Hg for 240 minutes. Swine in the survivor group (n=15) also underwent TBI and hemorrhage, and resuscitation with HEX was compared to that of normal saline (NS)+MAN. Neurologic outcome and coagulation were evaluated for 72 hours. Results In the nonsurvivor protocol, HEX, LR+MAN, and HEX+MAN attenuated the time-related rise of ICP and prevented ICP >20 mm Hg versus LR alone (P < .05). HEX alone maintained CPP (relative to baseline) and decreased total IVF by 50% versus LR ± MAN (P < .05). MAN had no additive effect with HEX. Coagulation, measured by thromboelastograph reaction time (R), was 11 ± 1 and 9 ± 1 minutes at baseline and after TBI (before randomization). At 240 minutes after HEX or LR+MAN, R was 6 ± 1 or 7 ± 2 minutes, which indicates a hypercoagulable state, but there was no difference between treatments. In the survivor protocol, ICP and CPP were similar with NS+MAN versus HEX, but IVF requirement was 161 ± 20 versus 28 ± 3 mL/kg (P < .05). Motor scores were higher on days 2 and 3 with HEX (P < .05). At 72 hours, R was 28 ± 14 versus 26 ± 6 minutes with NS+MAN versus HEX, which indicates a hypocoagulable state, but there was no difference between treatments. Conclusions Hextend as the sole resuscitation fluid after severe TBI reduces fluid requirement, obviates the need for mannitol, improves neurologic outcome, and has no adverse effect on the coagulation profile relative to the crystalloid plus mannitol standard of care.

UR - http://www.scopus.com/inward/record.url?scp=3843060380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843060380&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2004.05.011

DO - 10.1016/j.surg.2004.05.011

M3 - Article

C2 - 15300202

AN - SCOPUS:3843060380

VL - 136

SP - 355

EP - 363

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 2

ER -